Gentuity and GE HealthCare Team Up to Enhance Intravascular Imaging Solutions in the U.S.

Gentuity Collaborates with GE HealthCare to Expand Intravascular Imaging Access

Gentuity LLC, a prominent medical technology firm from Massachusetts, has made a significant announcement regarding their collaboration with GE HealthCare. This partnership is set to enhance the availability of Gentuity's next-generation intravascular imaging solutions, particularly the innovative High-Frequency OCT Imaging System and the Vis-Rx® PRIME Micro-Imaging Catheter, in cardiac catheterization labs across the United States.

Both companies aim to radically transform patient care by providing advanced imaging tools designed for more precise planning and treatment during percutaneous coronary interventions (PCIs). The partnership not only aims to elevate the standards of cardiac care but also signifies a broader commitment to enhancing clinical outcomes through innovative medical technologies.

Desmond Adler, President of Gentuity, expressed enthusiasm about the collaboration, stating, "The relationship with GE HealthCare offers a unique opportunity to significantly broaden the reach of our HF-OCT intravascular imaging technology to both physicians and patients throughout the U.S. This partnership will empower healthcare professionals with technologies that enhance clinical decision-making and improve patient outcomes."

GE HealthCare's CEO for CardioVascular and Interventional Solutions, Jyoti Gera, also highlighted the importance of this collaboration. Gera noted, "We are thrilled to combine Gentuity's cutting-edge imaging technology with our integrated cath lab solutions to facilitate more precise PCI planning. This partnership builds on our preceding strong relationship and aims to deliver enhanced visualization during procedures, instilling greater confidence in clinicians who manage complex cases."

The high-frequency OCT imaging system promises to optimize procedural workflows, and both firms recently showcased their collaborative innovation at the Transcatheter Cardiovascular Therapeutics (TCT) Conference. This event is recognized as a leading global meeting focused on interventional cardiovascular medicine. At the conference, Gentuity's imaging capabilities were prominently featured alongside GE HealthCare's portfolio, which reinforced the potential for leveraging integrated imaging modalities to improve workflow efficiency in catheterization labs.

Moreover, the two companies have commitments to display their advanced technologies together at the upcoming Cardiovascular Research Technologies Conference, scheduled for March 7-10, 2026. This event presents another platform for Gentuity and GE HealthCare to highlight their joint ventures and share their vision of enhanced patient care through innovative medical solutions.

Gentuity is dedicated to remaining at the forefront of technological advancements in the medical field. The company’s HF-OCT Imaging System reflects its commitment to delivering the latest breakthroughs in intravascular imaging. This system is designed for optimal usability, providing comprehensive visualization that allows for thorough assessment and planning by healthcare providers.

Additionally, the Vis-Rx® PRIME Micro-Imaging Catheter, known for its ultra-low profile of 1.8F, enables clinicians to conduct rapid imaging, ensuring full-vessel clarity in just one pullback. This capability is vital for real-time decision-making during critical PCI procedures.

With seamless integration into existing clinical workflows, Gentuity's solutions represent a new era of intravascular imaging technology. This partnership with GE HealthCare signifies a pivotal move towards advancing the overall quality of cardiovascular care, allowing healthcare providers to focus more on their patients’ needs.

For healthcare professionals eager to learn more about Gentuity’s revolutionary products, further information can be found on their official website: www.gentuity.com. For inquiries, reach out via email at [email protected]